Literature DB >> 16198198

Genomic approaches to schizophrenia.

Michael J Owen1.   

Abstract

BACKGROUND: Genetic epidemiologic studies suggest that individual variation in susceptibility to schizophrenia is substantially genetic. However, like other common disorders, the mode of transmission is complex and probably reflects oligogenic inheritance against a polygenic background.
OBJECTIVE: The goal of this article was to introduce genomics as an approach to understanding the causes of schizophrenia.
CONCLUSIONS: Genomic approaches to schizophrenia are becoming increasingly feasible as data from the Human Genome Project accumulate and technology improves. Attempts to identify genes for schizophrenia have been based on 4 main approaches: genetic linkage studies, studies of chromosomal abnormalities associated with the disorder, association studies, and convergent genomics. Several strong linkages have been found, and there is emerging consensus regarding at least some of the chromosomal regions likely to contain schizophrenia genes. However, moving from linked region to susceptibility gene is still difficult, given our poor understanding of the pathophysiology and population genetics, and the complexity of the phenotype. Despite this difficulty, positional candidate genes have been identified, and in 2 instances-neuregulin 1 and dysbindin-1-support has come from several studies. The rates of schizophrenia seen in individuals with deletions of chromosome 22q11, as well as linkage data,suggest that this chromosomal region might contain a susceptibility locus.

Entities:  

Mesh:

Year:  2005        PMID: 16198198     DOI: 10.1016/j.clinthera.2005.07.014

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  6 in total

1.  Generalized genomic distance-based regression methodology for multilocus association analysis.

Authors:  Jennifer Wessel; Nicholas J Schork
Journal:  Am J Hum Genet       Date:  2006-09-21       Impact factor: 11.025

2.  Effect of COMT Val108/158Met genotype on risk for polydipsia in chronic patients with schizophrenia.

Authors:  Kenji Yamada; Takahiro Shinkai; Hsin-I Chen; Kensuke Utsunomiya; Jun Nakamura
Journal:  Neuromolecular Med       Date:  2014-01-18       Impact factor: 3.843

3.  Involvement of PTPN5, the gene encoding the striatal-enriched protein tyrosine phosphatase, in schizophrenia and cognition.

Authors:  Ilana Pelov; Omri Teltsh; Lior Greenbaum; Amihai Rigbi; Kyra Kanyas-Sarner; Bernard Lerer; Paul Lombroso; Yoav Kohn
Journal:  Psychiatr Genet       Date:  2012-08       Impact factor: 2.458

4.  Association of catechol-O-methyltransferase gene polymorphisms with schizophrenia and negative symptoms in a Chinese population.

Authors:  Wen Jun Li; Chang Gui Kou; Yaqin Yu; Shilong Sun; Xuan Zhang; Thomas R Kosten; Xiang Yang Zhang
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-02-21       Impact factor: 3.568

5.  Whole genome association study in a homogenous population in Shandong peninsula of China reveals JARID2 as a susceptibility gene for schizophrenia.

Authors:  Yang Liu; Gang Chen; Nadine Norton; Wenmin Liu; Haining Zhu; Peng Zhou; Meng Luan; Shulin Yang; Xing Chen; Liam Carroll; Nigel M Williams; Michael C O'Donovan; George Kirov; Michael J Owen
Journal:  J Biomed Biotechnol       Date:  2009-10-27

6.  Methamphetamine enhances the development of schizophrenia in first-degree relatives of patients with schizophrenia.

Authors:  Huabing Li; Qiong Lu; Enhua Xiao; Qiuyun Li; Zhong He; Xilong Mei
Journal:  Can J Psychiatry       Date:  2014-02       Impact factor: 4.356

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.